You searched for "macular"

2422 results found

The eye without tears

The Art is long and Life is short. So goes the dispiriting tag in Latin and flung from day one and at regular intervals thereafter at idle medical students who, inevitably brainwashed, come by graduation to believe that the only...

Anterior segment OCT imaging in cases of episcleritis and scleritis

The purpose of this study was to determine whether it is feasible to obtain good-quality images with anterior segment OCT (AS-OCT) in patients with episcleral or scleral inflammation located anterior to the equator, and whether this technique is able to...

Gene therapy for inherited retinal disease: the Manchester Ocular Gene Therapy Group MDT service

The authors describe the process set up in Manchester for the optimum delivery and assessment of a new gene therapy treatment for patients with RPE65 IRD. Inherited retinal dystrophies (IRDs) are the second commonest cause of severe visual impairment in...

An update on inherited retinal disorders (part 2): Approaches to therapy for IRDs

Part 1 of this topic can be found here There are currently no proven cures for inherited retinal disease (IRD). However, multiple avenues of research are being investigated to better understand disease mechanisms and trial potential therapies that may slow...

Sight Sciences: Early Intervention with Implant-Free MIGS. The OMNI Surgical System

Agenda 18:30 Arrival & Refreshments19:00 Introductions & Welcome : Ms. Indira Madgula (Moderator), Royal Preston Hospital19:15 The Patients’ Perspective : Why MIGS, Why OMNI: Dr. Andrew Tatham, Princess Alexandra Eye Pavilion, Edinburgh19:45 Q&A - Discussion20:15 Close - Buffet Dinner

New study maps priorities for UK eyecare research

Glaucoma, age-related macular degeneration, childhood vision loss, and short-sightedness are highlighted as target study areas.

CHEC launches vitreoretinal surgery service

CHEC, a community healthcare provider delivering specialist ophthalmology services in partnership with the NHS has announced it is now offering innovative vitreoretinal surgery service from some of its hospitals. The specialised field of ophthalmology focuses on treating a range of...

The disease burden of AMD

In this multi-centre, prospective, observational, time and motion study the authors assessed the time burden of managing wet AMD for doctors, staff, patients and caregivers in the USA. The study spanned the period from March 2011 to August 2012, and...

Endophthalmitis after intravitreal injections in France

In this nationwide, retrospective, multicentre case series, the authors looked at the incidence and characteristics of endophthalmitis after intravitreal injections of anti-VEGFs and steroids, given for a variety of posterior segment conditions (macular oedema secondary to diabetes or retinal vein...

RPE atrophy onset in treated nAMD

In this study the authors aim to evaluate the role of various factors for the development of retinal pigment epithelium (RPE) atrophy over a period of five years in patients with nAMD. Fifty-two newly diagnosed nAMD patients with complete absence...

Results of vitrectomy in epiretinal membranes secondary to retinal vein occlusions

This retrospective, observational multicentre study investigated the anatomic and functional results of vitrectomy associated with the peeling of secondary epiretinal membranes (ERM) in patients with retinal vein occlusion (RVO) and determined the prognostic factors of surgical outcomes. Data was collected...

Everyday diabetes medicine could treat common cause of blindness

Doctors have found that metformin, an everyday medicine for diabetes, is associated with less progression of age-related macular degeneration (AMD), the commonest cause of blindness in western countries. People with diabetes over the age of 55 years taking metformin were...